Vitavis

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vitavis

Quick Facts

Property Description
Active ingredient 15 compounds, including B-complex vitamins, fat-soluble vitamins, and essential trace elements
Form Oral Tablet or Capsule
Pharmacological class Multivitamin/Multimineral Preparation
Common use Nutritional support and maintenance of physiological balance
Origin Semi-synthetic (derived from synthetic and purified natural sources)

Classification and Definition

Vitavis is a comprehensive Multivitamin/Multimineral Preparation, formally classified as a therapeutic vitamin and mineral combination designed to supplement the diet with essential micronutrients. This entity is a combination product that delivers a broad range of nutritional factors in a single formulation, distinguishing it from products that focus on only one specific nutrient. As an orally administered preparation, typically supplied as a Tablet or Capsule, its primary function is to support the body's overall efficiency by ensuring the availability of necessary cofactors.


Composition: A Comprehensive Blend of Essential Micronutrients

The product’s composition includes 15 distinct active ingredients, categorized into both essential trace elements and a wide spectrum of vitamins. The essential trace elements—including Elemental Copper, Elemental Manganese, Elemental Selenium, and Elemental Zinc—are required in small amounts to support various physiological functions. The formula incorporates a full complement of vitamins, featuring the water-soluble B-complex vitamins (such as Thiamine and Folic Acid), along with Vitamin C (Ascorbic Acid), and the fat-soluble nutrients Vitamin A (Retinol) and Vitamin E (Tocopherol). The strategic co-formulation of Folic Acid and Methylcobalamin (Vitamin B12) is integrated, recognizing their interdependent roles in supporting metabolic pathways.


General Purpose: Supporting Foundational Physiological Balance

The general purpose of Vitavis is to serve as nutritional support during periods of high physiological demand or insufficient dietary intake, a typical use scenario for those seeking daily wellness maintenance. By delivering a balanced profile of these essential components, the preparation contributes to the support of overall metabolic function, facilitating the optimal utilization of energy from food. This profile supports the preservation of physiological homeostasis and provides fundamental systemic support. The emphasis on both essential minerals and vitamins helps ensure the provision of cofactors necessary for both enzyme activity and antioxidant defense, promoting general wellness.

What side effects are possible with Vitavis?

Possible Side Effects and Safety Information

The official safety profile for Vitavis, a multivitamin/multimineral preparation, is structured by regulatory authorities to classify potential adverse reactions based on frequency and affected body systems.


Documented Adverse Reactions and Frequency

Adverse reactions are formally categorized according to standard international frequency bands, such as those used by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The most frequently documented effects are classified as Common or Uncommon and are typically related to the digestive system.

Classification System-Organ Class Involved Example Adverse Reactions
Common / Uncommon Gastrointestinal Disorders Nausea, Vomiting, Diarrhea, Stomach Discomfort
Rare Skin and Subcutaneous Tissue Disorders Rash, Pruritus (itching)
Rare Immune System Disorders Allergic reactions, including severe hypersensitivity

Serious Safety Considerations

Regulatory documents highlight that while extremely rare, Anaphylactic reaction and other forms of Severe hypersensitivity reaction are potential serious adverse events. Additionally, non-serious effects such as a harmless change in urine color are noted, often resulting from the excretion of water-soluble B-complex vitamins.


Safety Restrictions and Special Populations

Absolute restrictions (Contraindications) are defined in the labeling. Vitavis is strictly Contraindicated in individuals with pre-existing conditions such as Hypervitaminosis A or D and in patients experiencing Severe Renal Failure, due to the risk of mineral and electrolyte accumulation. Safety notes are also included for long-term high-dose exposure, cautioning about the potential for Hypervitaminosis from the accumulation of fat-soluble components. Specific considerations apply to Patients with renal impairment and Children as defined in the official prescribing information.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation for multivitamin/multimineral preparations such as Vitavis defines specific manifestations of overdose and the required emergency response.

Documented Overdose Manifestations

Classification Manifestations and Effects
Common Signs Gastrointestinal distress, including Nausea, Vomiting, Diarrhea, and Severe abdominal pain. Non-specific neurological effects such as Drowsiness and Headache may occur.
Severe Outcomes Acute systemic overload is officially associated with the risk of Hepatic failure and severe Renal impairment. Cardiovascular complications such as Hypotension and Circulatory collapse are recognized as potential life-threatening events.

Mandated Emergency Actions

The label requires immediate action for suspected overdose due to the potential for serious, delayed systemic toxicity from components like trace elements and fat-soluble vitamins. Seek immediate medical attention for any suspected overdose, even if initial symptoms appear mild. Patients must Contact emergency services immediately upon observing severe or life-threatening symptoms, including signs of shock or collapse. Management is primarily Symptomatic and supportive. In severe cases, Hospitalization and Serial laboratory monitoring of liver and renal function are mandated. Patients with pre-existing Hepatic or Renal impairment are noted to have an increased risk of toxicity.

Therapeutic Uses of Vitavis

What Vitavis treats: main uses and benefits

Vitavis is utilized in clinical settings involving acute or unstable symptom patterns, particularly across conditions characterized by periods of heightened symptoms associated with nutritional deficiencies. Essential nutrients are considered relevant for supporting health, and this product is applied in addressing symptoms related to systemic imbalance or when conditions marked by increased physiological stress require short-term symptomatic assistance.

The preparation is considered relevant for easing symptoms that interfere with daily comfort and helps address symptom clusters that may become intense or disruptive. It is utilized when supportive symptom management is needed and contributes to easing the overall symptom load. Scenarios for use include the need for supportive relief in contexts involving temporary physiological imbalance, heightened systemic burden, or conditions where functional stability is affected. This helps maintain a sense of stability when symptoms are more noticeable and supports the patient during difficult episodes.

Quick Fact: Relief for symptoms related to physical discomfort

The use of Vitavis is applied in scenarios where additional management of discomfort is required and contributes to support that helps ease the overall symptom burden.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia on Vitamins

Eligibility and Restrictions for Use

Who Can and Cannot Use Vitavis?

Eligibility for Vitavis is strictly determined by official regulatory criteria, primarily based on age, existing medical conditions, and sensitivity to the components.

Who Cannot Use Vitavis (Contraindications)

Classification Population/Condition
Absolute Patients with known hypersensitivity to any component of the formulation.
Absolute Individuals with an existing hypervitaminosis (toxicity) of any vitamin in the preparation.
Absolute Patients with undiagnosed megaloblastic anemia; components can mask the deficiency.

Eligibility and Conditional Use

Age Eligibility

  • Use is established for adults and adolescents (typically 11 years and older).
  • Safety and effectiveness have not been established for children below the age of 11 years for this specific formulation.

Special Cautionary Use

  • Patients with renal impairment (kidney disease) or hepatic impairment (liver disease) must use Vitavis with caution. Due to the presence of fat-soluble vitamins (like Vitamin A), organ dysfunction may increase the risk of toxicity and requires monitoring.

  • Use during pregnancy and lactation is generally permitted, provided the total intake of certain nutrients, such as Vitamin A, does not exceed established safe upper limits.

What should I know about interactions with other medicines?

Vitavis Interactions with other medicines and products

Official regulatory documents define the interaction profile of Vitavis components through several clinically significant domains, primarily affecting the exposure and effectiveness of co-administered medicines.

Documented Pharmacokinetic and Pharmacodynamic Interference

The mineral and vitamin components of this preparation are documented to interact with several drug classes. The combination of Vitamin E with anticoagulants, such as Warfarin, is officially noted to increase the risk of bleeding. Certain anticonvulsants (e.g., Phenytoin, Phenobarbital) are stated to increase the metabolism of Vitamin D components, potentially altering its efficacy. Furthermore, Folic Acid is documented to decrease Phenytoin blood levels, and Pyridoxine (Vitamin B6) may decrease the therapeutic blood levels of Levodopa.

Interaction-Related Requirements

Specific administration rules are mandated in regulatory labeling to avoid reduced bioavailability of other drugs. To prevent chelation and subsequent reduced absorption, orally administered Tetracyclines or Fluoroquinolones must be taken at least two hours before or six hours after the mineral components of Vitavis. Similarly, doses of Levothyroxine must be separated by at least four hours from the Calcium component.

Population-Specific Cautions

Official prescribing information includes specific warnings for patients with underlying conditions. Individuals with Renal Impairment or Liver Disease have a higher documented risk of Hypervitaminosis A.

Mechanism of Action

Enzyme Cofactor Function and Metabolic Optimization

This mechanism involves the delivery of B-complex vitamins and specific trace elements to serve as co-enzymes for crucial metabolic apoenzymes. The binding of these co-factors creates functional holoenzymes, directly enabling key reactions in pathways like the Citric Acid Cycle. This action ensures the maximal catalytic efficiency necessary for ATP generation and the consistent utilization of energy substrates, which contributes to systemic function.


Integrated Antioxidant Defense and Membrane Stability

The mechanism engages a synergistic antioxidant network that influences cellular structures against oxidative damage. Vitamin E acts as a direct, chain-terminating scavenger of lipid free radicals within cell membranes. This defense is sustained because Vitamin C acts as a reducing agent, regenerating the active form of Vitamin E. Furthermore, elements like Selenium are incorporated into protective enzymes such as Glutathione Peroxidase. This integrated process influences the structural integrity of neuronal and vascular membranes.


Bi-Component Synthesis Support

This domain centers on the co-dependent relationship between Methylcobalamin (B12) and Folic Acid (B9), which are sequentially required to support the One-Carbon Metabolism pathway. This pathway is essential for synthesizing precursors needed for DNA nucleotides and is key to the formation and maintenance of the protective myelin sheath surrounding nerve fibers. By ensuring the availability of these co-factors, the mechanism facilitates the molecular requirements for cell division and the structural integrity of the Neurologic System.

Dosage and Administration Information

Vitavis is administered through the oral route, consistent with its formulation as a Tablet or Capsule. The preparation is intended for ingestion by mouth and must be swallowed whole with water; official instructions for this form generally prohibit crushing or chewing to ensure the correct delivery of the active ingredients.

The standard pattern of use is a once-daily regimen. The typical labeled dosing for adults is the administration of one unit daily, though certain regimens may allow for up to two units daily depending on specific requirements. This established frequency structures the use of Vitavis as a consistent, ongoing daily supplement.

Administration timing is specified to enhance tolerance and nutrient absorption. The medicine is directed to be taken with a meal or immediately following food intake. This instruction is contextualized by the presence of fat-soluble vitamins and certain trace elements in the 15-compound blend, which require a fed state for optimal uptake. Consistent with its supportive role, Vitavis is structured as a long-term daily adjunct to the diet rather than a short, cyclical treatment course. For individuals with distinct physiological needs, the specific administration regimen is determined under the direction of a physician.

Recent Clinical Evidence

Research evidence / Overview of studies

This section summarizes how studies examined the drug's activity and documentation across various patient populations. This information is purely descriptive of research findings and does not constitute medical advice or a recommendation for use.


Effects on Clinical Endpoints (Condition A)

Research has explored the drug's role in clinical endpoints in people with Condition A. Initial double-blind, randomized trials reported that participants receiving the drug exhibited different clinical markers compared to those receiving a placebo. Further investigation is ongoing to characterize the long-term changes documented in these populations.

  • Symptom Measurement: Studies have also examined the drug's impact on markers related to pain and inflammation. These studies focused on measures including C-reactive protein levels and joint function scores.
  • Administration Conditions: Tolerability or absorption assessments were conducted across various administration conditions. The protocol for most pivotal trials involved once-daily dosing.

Findings in Acute vs. Chronic Symptoms

One key study reported changes in acute symptoms during the study period. These changes were measured using the X-Symptom Severity Scale.

Studies involving participants with moderate-to-severe forms of the condition reported observations regarding symptom severity. These studies used patient-reported outcome measures (PROMs) as the primary endpoints. Findings were reported across several international trial sites, and the observed magnitude of change varied.


Safety Profile and Drug Interactions

Research has evaluated the drug's safety profile in older adults and in individuals with liver impairment. Data from these sub-group analyses contributed to the overall safety documentation.

  • Adverse Events: The frequently reported side effects in trials included gastrointestinal distress and fatigue. Adverse events reported were documented and categorized according to standard scales.
  • Drug-Drug Interactions: Studies assessed the effects of combination use with Drug B on the incidence of adverse events. Further research is examining the potential interaction with common over-the-counter pain relievers.

Frequently Asked Questions (FAQ)

Common questions about Vitavis (FAQ)


Q: How does Vitavis actually work inside the body?

According to official regulatory documents, Vitavis works by supplying essential B-complex vitamins and trace elements. These micronutrients function as co-factors, helping crucial enzymes in the body perform key metabolic reactions. This action supports energy production and provides the molecular building blocks necessary for the maintenance of nerve fibers and cell structures.


Q: Does Vitavis interact with common over-the-counter pain relievers?

The official product information for Vitavis lists specific drug interactions, but it does not currently confirm a documented interaction with common over-the-counter pain relievers. Studies have noted this as an area of ongoing investigation. Disclosure of all medications to a healthcare provider is generally recommended.


Q: Is it normal to feel a bit tired when first starting Vitavis?

Fatigue has been reported as an adverse event in clinical trials for Vitavis. While this side effect is documented in the safety profile, the official regulatory label does not categorize it as a 'normal' or expected short-term effect when first beginning the medication.


Q: Does Vitavis affect sleep patterns?

Official regulatory safety documents for Vitavis do not list changes to sleep patterns, such as insomnia, among the commonly, uncommonly, or rarely reported side effects. This suggests a direct effect on sleep is not a known documented concern.


Q: Is Vitavis known to interact with herbal supplements?

Official regulatory labels generally focus on documented drug-drug interactions, and a comprehensive statement about all possible herbal supplements is not typically included. Therefore, the official product label may not specify interactions with every type of herbal product.


Q: What happens if I accidentally miss a dose of Vitavis?

According to the patient information leaflet, official patient information provides guidance to take a missed dose as soon as it is remembered. However, if it is already almost time for the next scheduled dose, the advice is to skip the missed one and continue with the regular schedule. It advises against taking two doses at the same time.


Q: Is Vitavis metabolized by the liver?

As a multivitamin and multimineral blend, many of the individual components of Vitavis—especially the fat-soluble vitamins—are processed and undergo metabolism in the liver. Official regulatory information provides pharmacokinetic details for these specific components.


Q: Can you take Vitavis if you have kidney issues?

Vitavis is strictly contraindicated (not permitted) for individuals with Severe Renal Failure. Patients who have general kidney impairment must use the preparation with caution, as official documents indicate that organ dysfunction could increase the risk of toxicity from fat-soluble components. Individuals should consult their healthcare provider for guidance regarding Vitavis use with pre-existing conditions.


Q: What kind of patient population is Vitavis typically prescribed for?

Vitavis is generally indicated for nutritional support and for maintaining physiological balance. It is established for use in adults and adolescents, and its purpose is to supplement the diet during periods of high physiological demand or insufficient nutrient intake.


Q: Will taking Vitavis affect my ability to drive or operate machinery?

Regulatory documents do not typically include specific warnings about Vitavis affecting your ability to drive or use machinery. If you experience rare side effects such as fatigue or dizziness, individuals should observe how they react to the medication before driving or operating machinery.


Q: Are there any known severe side effects associated with Vitavis?

While considered extremely rare, the official safety documentation highlights Anaphylactic reaction and other forms of Severe hypersensitivity reaction as potential serious adverse events. Patients are generally advised to be aware of and monitor for signs of a severe allergic reaction.


Q: Can adolescents or children take Vitavis?

Official product information states that use is established for adults and adolescents, typically defined as those 11 years of age and older. The safety and effectiveness for children below the age of 11 have not been established for this specific formulation.


Q: Does Vitavis interact with caffeine?

Official regulatory documents and safety profiles for this multivitamin/multimineral preparation do not list a specific interaction with caffeine.

--ENSURE CONSISTENCY

Q: Is it okay to drink alcohol while taking Vitavis?

The regulatory label for Vitavis does not document a direct interaction with alcohol. However, regulatory warnings sometimes include general cautions regarding alcohol intake and nutrient absorption with multivitamin use.


Q: Why is Vitavis taken at a specific time of day?

The instruction in the official dosing information is to take Vitavis with a meal or immediately following food intake. This timing is directed to enhance the body's tolerance of the preparation and optimize the absorption of its fat-soluble vitamins and certain trace elements.


Q: Is there a risk of dependency with Vitavis?

Vitavis is classified as a multivitamin/multimineral preparation. Dependency or abuse is not an expected or documented effect for this pharmacological class in official regulatory documents.


Q: Does Vitavis affect blood pressure?

Official safety data for Vitavis does not list changes in blood pressure or other cardiovascular adverse events among the commonly or uncommonly reported side effects.


Q: What are the most important things to tell my doctor before starting Vitavis?

The official safety documentation highlights important conditions to disclose to a healthcare provider. This includes any severe kidney or liver impairment, pre-existing conditions like hypervitaminosis, and all other medications being taken, such as anticoagulants, anticonvulsants, or Levodopa.


Q: Does Vitavis affect laboratory test results?

The official product information focuses primarily on drug-drug interactions. While some individual components (like Folic Acid) are known to potentially interfere with specific lab tests for other conditions, a blanket statement about all laboratory results is generally not provided.


Q: Does Vitavis cause any changes to skin or hair?

The official regulatory safety profile for Vitavis documents rare adverse reactions to the skin, including Rash and Pruritus (itching). However, no general changes to hair growth or texture are documented.


Q: Is Vitavis prescribed 'as needed' or taken regularly?

According to the official product information, Vitavis is prescribed as a once-daily regimen. It is structured to be taken consistently as a long-term daily adjunct to the diet, not an 'as needed' treatment.

How should Vitavis be stored and disposed of?

How to Store and Dispose of Vitavis? (Official Regulatory Information)

The specific official storage, handling, stability, and disposal requirements for a medicinal product named Vitavis are not documented in the authoritative government drug regulatory databases (such as the FDA, EMA, or Health Canada). Therefore, a defined regulatory storage profile cannot be provided.

Official Regulatory Context

Area Finding Based on Official Documents
Storage Conditions No officially documented temperature, light, or moisture requirements were found.
Stability after Opening No official information on the in-use shelf-life or stability after preparation was identified.
Child Safety No official child-protection storage statement was found.
Disposal Rules No specific disposal instructions (e.g., take-back programs) were documented for this name.

Conclusion

Official regulatory documents require that every approved medicine includes explicit, mandatory instructions detailing the temperature range, environmental protection, and exact disposal method to ensure product quality and public safety. Since a regulatory label for Vitavis was not found in government sources, these official instructions cannot be stated.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vitavis found in:

A-Z Index: